Agenus Inc. (AGEN) financial statements (2020 and earlier)

Company profile

Business Address 3 FORBES ROAD
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:935360761724027
Cash and cash equivalents935360711372627
Short-term investments   53515 
Other undisclosed cash, cash equivalents, and short-term investments 00(0)0  
Receivables2111110 0
Inventory, net of allowances, customer advances and progress billings000000
Inventory000000 
Prepaid expense1019113211
Other current assets1111110
Other undisclosed current assets (0)(0)0(0)  
Total current assets:1077574911844328
Noncurrent Assets
Operating lease, right-of-use asset8
Property, plant and equipment252526261563
Intangible assets, net (including goodwill)3435373942253
Goodwill2323232223183
Intangible assets, net (excluding goodwill)11121416197 
Other noncurrent assets1111111
Total noncurrent assets:6862656658327
TOTAL ASSETS:1751361381572427535
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities453830331975
Accounts payable161485421
Accrued liabilities292522281464
Deferred revenue34
Debt150 0014
Deferred revenue and credits43402
Contract with customer, liability2
Other liabilities0025610
Other undisclosed current liabilities382721    
Total current liabilities:13368564129910
Noncurrent Liabilities
Long-term debt and lease obligation, including:813142131114  
Long-term debt, excluding current maturities 13142131114  
Operating lease, liability8
Other undisclosed long-term debt and lease obligation  (0)(0)   
Liabilities, other than long-term debt40715252865
Deferred revenue and credits8121533
Deferred revenue31
Contract with customer, liability1
Other liabilities4335832
Business combination, contingent consideration, liability43486 
Other undisclosed noncurrent liabilities199223     
Total noncurrent liabilities:24724315815514365
Total liabilities:3803112141961721515
Stockholders' equity
Stockholders' equity attributable to parent, including:(200)(172)(76)(39)7123(4)
Common stock1111110
Treasury stock, value      (0)
Additional paid in capital1,0551,005952867851716645
Accumulated other comprehensive loss(1)(2)(2)(2)(2)(2) 
Accumulated deficit(1,255)(1,177)(1,026)(905)(779)(691)(649)
Other undisclosed stockholders' equity attributable to parent 000000
Stockholders' equity attributable to noncontrolling interest(5)(2)     
Total stockholders' equity:(205)(175)(76)(39)7123(4)
Other undisclosed liabilities and equity  00 3624
TOTAL LIABILITIES AND EQUITY:1751361381572427535

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues1223743232573
Revenue, net00011
Cost of revenue
(Cost of Goods and Services Sold)
      (1)
Gross profit:1223743232573
Operating expenses(211)(162)(150)(128)(99)(45)(28)
Other undisclosed operating income (loss)(1)13(2)(7)(5)1
Operating loss:(90)(124)(104)(107)(81)(43)(25)
Nonoperating income (expense)(1)(2)2(2)(6)2(3)
Investment income, nonoperating 111200
Foreign currency transaction gain (loss), before tax (2)2(2)(1)10
Interest and debt expense (11)(31)(19)(0)(1)(6)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  122(6)  
Loss from continuing operations before income taxes:(91)(137)(121)(127)(93)(42)(33)
Income tax benefit    5  
Loss before gain (loss) on sale of properties:(91)(137)(121)(127)(88)(42)(33)
Other undisclosed net loss(38)(25)     
Net loss:(130)(162)(121)(127)(88)(42)(33)
Net income attributable to noncontrolling interest42     
Other undisclosed net income attributable to parent1     3
Net loss attributable to parent:(124)(160)(121)(127)(88)(42)(30)
Preferred stock dividends and other adjustments(0)(0)(0)(0)   
Other undisclosed net loss available to common stockholders, basic(1)   (0)(0)(3)
Net loss available to common stockholders, diluted:(126)(160)(121)(127)(88)(43)(33)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(130)(162)(121)(127)(88)(42)(33)
Other comprehensive income (loss)01(1)1(0)(2) 
Comprehensive loss:(129)(161)(121)(126)(88)(44)(33)
Comprehensive income, net of tax, attributable to noncontrolling interest42     
Other undisclosed comprehensive loss, net of tax, attributable to parent    (0)(0) 
Comprehensive loss, net of tax, attributable to parent:(125)(159)(121)(126)(88)(45)(33)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: